Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.92 USD | +1.65% | -2.20% | -6.91% |
Evolution of the average Target Price on Celldex Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Celldex Therapeutics, Inc.
TD Cowen | |
Wells Fargo Securities | |
HC Wainwright | |
Guggenheim | |
SVB Securities LLC | |
Jefferies & Co. | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- CLDX Stock
- Consensus Celldex Therapeutics, Inc.